Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.

Autor: Tian, H1, Liu, J, Chen, J1, Gatza, M L2, Blobe, G C
Zdroj: Oncogene. 11/5/2015, Vol. 34 Issue 45, p5635-5647. 13p. 1 Diagram, 7 Graphs.
Databáze: Academic Search Ultimate